We will be announcing at the Veterinary Cancer Society Annual Conference 2026 (Minneapolis  Sept 24-26) the launch of FL9-Tissue Core, a groundbreaking tumour sequencing panel aimed at sequencing tumour tissue in cats and are working on liquid biopsy for cats with the launch of FL9-Liquid DX in May 2027.

FL9-Tissue Core ™ is our first in class sequencing panel aimed at sequencing tumour tissue for cats. to identify key molecular intervention in felines. It allows to study most commonly mutated oncogenes, tumour suppressor genes and other cancer-related genes in felines.